Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
04:00:00 EDT Mon 26 Oct 2026
Enter Symbol
or Name
USA
CA



News last 24 hour(s) - 40 items News ReleasesIn The NewsOther CAUS
DateSymPriceTypeHeadline
2026-10-26 03:30U:BMYNews ReleaseIzalontamab Brengitecan (Iza-Bren) Doubles Median Progression-Free Survival in Patients with Previously-Treated EGFR-Mutated Non-Small Cell Lung Cancer Compared to Chemotherapy in the Phase 3 PANKU-Lung01 Study
2026-10-26 03:15U:UUUFFNews ReleaseUranium One Mining Corp. Engages Adrian Huerta Ruiz as Technical Advisor for Athabasca Basin Uranium Exploration
2026-10-26 03:15U:CEXYFNews ReleaseCopper One Commences Up to 10,000 Foot Phase 2 Drill Program at Flagship Majuba Hill Copper-Silver-Gold Project, Nevada
2026-10-26 03:05U:LIFFFNews ReleaseLi-FT Announces First Results from Summer Drill Program at the Adina-Galinee Lithium Project, Quebec
2026-10-26 03:01U:RKMSFNews ReleaseRokmaster Drills Stockwork and Porphyry at Mystery
2026-10-26 03:00U:STMNews ReleaseSTMicroelectronics introduces first automotive safety combination sensors for mass-market applications
2026-10-26 03:00U:NHYDYNews ReleaseNorsk Hydro: Reminder - Invitation to Hydro's Investor Day, London
2026-10-26 03:00U:IHGNews ReleaseInterContinental Hotels Group PLC Announces Transaction in Own Shares - October 26
2026-10-26 03:00U:ICHGFNews ReleaseInterContinental Hotels Group PLC Announces Transaction in Own Shares - October 26
2026-10-26 02:01U:DMXCFNews ReleaseDistrict Reports on Geochemical Results from Nianfors Uranium Property in Sweden
2026-10-26 02:00U:PSRHFNews ReleaseHelium Added to U.S. Department of Energy Critical Material List
2026-10-25 22:19U:PIMLFNews ReleasePinnacle Minerals Limited (PIMLF) Acquires Rights to Five Utah Tungsten Projects USA
2026-10-25 21:57U:URRNFNews ReleaseEverest Metals Corporation Ltd (URRNF) Mt Edon Project Gains International Recognition Through European Strategic Initiatives
2026-10-25 21:00U:NDAQNews ReleaseNasdaq Strengthens Asia-Pacific Leadership Team
2026-10-25 20:48U:FFRNews ReleaseFFR to Hold Listing Ceremony and Investor Day on October 26; FFAI Announces Rescheduling of YT Jia's Investor Weekly Report to October 26
2026-10-25 20:48U:FFAINews ReleaseFFR to Hold Listing Ceremony and Investor Day on October 26; FFAI Announces Rescheduling of YT Jia's Investor Weekly Report to October 26
2026-10-25 20:00U:OPNWNews ReleaseOpenWorld Confirms Dual Listing on Figure OPEN on Track for Q4 2026 Following Stockholder Approval of Blockchain Common Stock
2026-10-25 20:00U:OPNWNews ReleaseOpenWorld Confirms Dual Listing on Figure OPEN on Track for Q4 2026 Following Stockholder Approval of Blockchain Common Stock
2026-10-25 20:00U:HCMNews ReleaseHUTCHMED Highlights SAFFRON Global Phase III Data Presented at ESMO Congress 2026 and Simultaneously Published in The New England Journal of Medicine
2026-10-25 19:56U:FFAINews ReleaseFaraday Future Announces YT Jia's Investor Weekly Report Rescheduled to October 26; FFR to Hold Listing Ceremony and Investor Day on October 26
2026-10-25 19:51U:RLMLFNews ReleaseResolution Minerals Ltd (RLMLF) Drilling Confirms Extension of Gold Zone at Golden Gate
2026-10-25 19:32U:SYAXFNews ReleaseElevra Lithium Limited (ELVR) Sale of Ewoyaa Project Interest Completed
2026-10-25 19:32U:ELVRNews ReleaseElevra Lithium Limited (ELVR) Sale of Ewoyaa Project Interest Completed
2026-10-25 17:55U:ELEKNews ReleaseThe Next American Lithium Chapter? ELEKTROS Pursues Due Diligence Near the Canadian Border
2026-10-25 17:30U:ELEKNews ReleaseOctober Spotlight on ELEK: A Potential U.S. Lithium Play Meets the EV Revolution
2026-10-25 16:30U:ELEKNews ReleaseAmerica First in Lithium Logistics: Elektros Eyes a New York Resource Opportunity
2026-10-25 12:00U:ORKANews ReleaseOruka Therapeutics to Host Conference Call to Report Week 16 Data for ORKA-001 from the Ongoing EVERLAST-B Trial on October 26, 2026
2026-10-25 11:52U:SMMTNews ReleaseIvonescimab Plus Chemotherapy Demonstrates Overall Survival Superiority Compared to Durvalumab Plus Chemotherapy in First-Line Treatment of Patients with Advanced Biliary Tract Cancer in HARMONi-GI1 Study Conducted by Akeso in China
2026-10-25 11:35U:AZNNews ReleaseSonesitatug vedotin reduced the risk of death by 42% in 2nd and later-line CLDN18.2-positive advanced gastric/GEJ cancers in CLARITY-Gastric01
2026-10-25 11:30U:RHHBYNews ReleaseGenentech's Divarasib Demonstrated Best-in-Class Efficacy, Advancing the Standard of Care in Previously Treated KRAS G12C-mutated Lung Cancer
2026-10-25 11:30U:AZNNews ReleaseTAGRISSO(TM) (osimertinib) plus savolitinib reduced the risk of disease progression or death by 45% and the risk of death by 32% in MET-driven EGFR-mutated lung cancer after progression on TAGRISSO
2026-10-25 09:45U:JNJNews ReleaseRYBREVANT FASPRO(TM) (amivantamab and hyaluronidase-lpuj) combination demonstrates 77% overall response rate in first-line treatment of patients with advanced head and neck cancer
2026-10-25 09:00U:AVBPNews ReleaseArriVent Announces Initial Phase 1 Data for CDH17-targeted ADC ARR-217 in Patients with Gastrointestinal Cancers at ESMO Congress 2026
2026-10-25 08:11U:AMRNNews ReleaseAmarin Provides Update on University of Leeds Sponsored Phase 3 EPA for Metastasis Trial 2 (EMT2) Evaluating VAZKEPA(TM)/VASCEPA(TM) (icosapent ethyl) Capsules on Top of Standard of Care Treatment in Patients Undergoing Liver Resection for Colorectal Canc
2026-10-25 07:00U:NBPNews ReleaseNovaBridge Biosciences Reports Mature Phase 1b Data at ESMO 2026 Positioning Givastomig for Registrational Development
2026-10-25 07:00U:GMABNews ReleaseGenmab Announces Updated Follow-Up Analyses from Phase 2 Study of Petosemtamab Demonstrate Meaningful Objective Response Rates in Patients with Metastatic Colorectal Cancer
2026-10-25 07:00U:AGENNews ReleaseAgenus Reports 72% of Patients with Locally Advanced dMMR Colon Cancer Had No Cancer Remaining at Surgery Following Six Weeks of BOT+BAL in Phase 2 NEOASIS Study at ESMO 2026
2026-10-25 06:22U:BORRNews ReleaseBorr Drilling Limited - Prospector 5 Rig Incident
2026-10-25 05:15U:REGNNews ReleaseLibtayo(TM) (cemiplimab) Longer-Term Data Show Increasing and Clinically Meaningful Overall Survival Benefit with Adjuvant Treatment in High-Risk Cutaneous Squamous Cell Carcinoma (CSCC)
2026-10-25 04:35U:XNCRNews ReleaseXencor Presents Phase 1 Dose Selection Data for XmAb819, a Potential First-in-Class ENPP3 x CD3 Bispecific T-Cell Engager, in Development for Patients With Advanced Clear Cell Renal Cell Carcinoma and ENPP3+ Tumors